Livforsakringsbolaget Skandia, Omsesidigt Gilead Sciences, Inc. Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.85 Billion
Q4 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 10,317 shares of GILD stock, worth $1.09 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,317

Previous 10,717 3.73%

Holding current value

$1.09 Million

Previous $898,000 6.01%

% of portfolio

0.05%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$83.95 - $97.9 $33,580 - $39,160	-400 Reduced 3.73%	10,317 $952,000
Q3 2024 Oct 10, 2024	BUY	$66.59 - $83.99 $570,343 - $719,374	8,565 Added 398.0%	10,717 $898,000
Q2 2024 Jul 15, 2024	SELL	$63.15 - $72.88 $6.2 Million - $7.16 Million	-98,220 Reduced 97.86%	2,152 $147,000
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $90,488 - $102,616	1,235 Added 1.25%	100,372 $8.13 Million
Q3 2023 Oct 20, 2023	SELL	$73.94 - $80.67 $340,124 - $371,082	-4,600 Reduced 4.43%	99,137 $7.43 Million
Q2 2023 Jul 06, 2023	SELL	$76.01 - $86.7 $798,105 - $910,350	-10,500 Reduced 9.19%	103,737 $8 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.25 Million - $1.43 Million	-21,000 Reduced 15.53%	114,237 $7.05 Million
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $161,616 - $182,028	-2,800 Reduced 2.03%	135,237 $8.36 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $2.36 Million - $2.67 Million	36,300 Added 35.68%	138,037 $10 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $155,687 - $167,969	-2,300 Reduced 2.21%	101,737 $7.1 Million
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $425,249 - $464,644	6,700 Added 6.88%	104,037 $7.16 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $732,000 - $835,211	12,200 Added 14.33%	97,337 $6.29 Million
Q4 2020 Mar 02, 2021	BUY	$56.65 - $64.55 $317,240 - $361,480	5,600 Added 7.04%	85,137 $4.96 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $62,100 - $78,080	-1,000 Reduced 1.24%	79,537 $5.03 Million
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $256,783 - $328,902	4,100 Added 5.36%	80,537 $6.02 Million
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $351,234 - $386,346	-5,700 Reduced 6.94%	76,437 $4.97 Million
Q2 2019 Jul 19, 2019	BUY	$61.87 - $69.38 $160,862 - $180,388	2,600 Added 3.27%	82,137 $5.55 Million
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $81,289 - $91,065	1,300 Added 1.66%	79,537 $5.17 Million
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $1.8 Million - $2 Million	-25,300 Reduced 24.44%	78,237 $6.04 Million
Q2 2018 Jul 10, 2018	BUY	$64.88 - $75.68 $220,591 - $257,312	3,400 Added 3.4%	103,537 $7.34 Million
Q4 2017 Jan 18, 2018	SELL	$71.15 - $83.52 $747,075 - $876,960	-10,500 Reduced 9.49%	100,137 $7.17 Million
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $7.98 Million - $9.46 Million	110,637	110,637 $8.96 Million

Others Institutions Holding GILD

# of Institutions

2,045

Shares Held

Call Options Held

10M

Put Options Held

9.05M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Gilead Sciences, Inc. Transaction History